New drug combination approved in Wales for treating asthma
The All Wales Medicines Strategy Group has given its backing to a new combination of a long-acting beta2-agonist and inhaled corticosteroid.
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
Customised email alerts straight to your inbox (over 30 alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units